Preadipocyte IL-13/IL-13Rα1 signaling regulates beige adipogenesis through modulation of PPARγ activity
Journal
Journal of Clinical Investigation
Journal Volume
135
Journal Issue
11
Start Page
e169152
ISSN
1558-8238
Date Issued
2025-04-08
Author(s)
Yesian, Alexandra R.
Chalom, Mayer M.
Knudsen, Nelson H.
Hyde, Alec L.
Personnaz, Jean
Cho, Hyunjii
Liou, Yae-Huei
Starost, Kyle A.
Tsai, Dong-Yan
Ho, Hsing-Wei
Li, Jun
Hu, Frank B.
Banks, Alexander S.
Lee, Chih-Hao
Abstract
Type 2 innate lymphoid cells (ILC2s) regulate the proliferation of preadipocytes that give rise to beige adipocytes. Whether and how ILC2 downstream Th2 cytokines control beige adipogenesis remain unclear. We used cell systems and genetic models to examine the mechanism through which IL-13, an ILC2-derived Th2 cytokine, controls beige adipocyte differentiation. IL-13 priming in preadipocytes drove beige adipogenesis by upregulating beige-promoting metabolic programs, including mitochondrial oxidative metabolism and PPARγ-related pathways. The latter was mediated by increased expression and activity of PPARγ through the IL-13 receptor 1 (IL-13R1) downstream effectors STAT6 and p38 MAPK, respectively. Il13-KO or preadipocyte Il13ra1-KO mice were refractory to cold- or β3-adrenergic agonist–induced beiging in inguinal white adipose tissue, whereas Il4-KO mice showed no defects in beige adipogenesis. Il13-KO and Il13ra1-KO mouse models exhibited increased body weight and fat mass and dysregulated glucose metabolism but had a mild cold-intolerant phenotype, likely due to their intact brown adipocyte recruitment. We also found that genetic variants of human IL13RA1 were associated with BMI and type 2 diabetes. These results suggest that IL-13 signaling–regulated beige adipocyte function may play a predominant role in modulating metabolic homeostasis rather than in thermoregulation.
Subjects
Adipose tissue
Cell biology
Glucose metabolism
Metabolism
Obesity
Publisher
American Society for Clinical Investigation
Type
journal article